Equity research payments are due for massive disruption as the EU MiFID 2 Directive comes into effect in January 2017. The industry is expecting that it will separate research from execution, leaving both buy-side and sell-side pondering how to price and pay for research on its own.
On November 3, 2015, Slator held an executive roundtable at the Conrad Hotel in Hong Kong sponsored by Lionbridge on the future of equity research payments and the oncoming disruption brought about by EU MiFID 2. Participants included senior decision makers from Deutsche Bank, BNP Paribas, Morningstar, UBS, Nomura, CIMB, SocGen, Citibank, Shenwan Hongyuan, and others. This report, developed in cooperation with roundtable guest speaker Fabrice Bouland, CEO of Alphametry, provides an overview of the presentation and talking points discussed during the roundtable. “The upcoming MiFID II regulation is targeting Europe but the investment banks are well aware that any regional change of rules will have a profound impact on the industry globally,” Bouland commented on the urgency of the topic.


